Bio-Rad’s Q2 Revenues Rise 7 Percent, but Year-Ago Settlement Cuts Profit
 
Bio-Rad Laboratories this week said that its second-quarter revenues increased 7 percent as R&D spending rose 13 percent and profit tumbled 20 percent.
 
Total revenues for the three months ended June 30 increased to $339.1 million from $317.7 million year over year. On a currency-neutral basis, revenues increased 3 percent compared to the second quarter of 2006.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.